Common Myths and Misconceptions About Primary Angioplasty in Acute Myocardial Infarction: An Evidence-Based

Kunal Mahajan1, Jai Bharat Sharma1, Surender Himral1

  • 1Cardiology, Himachal Heart Institute, Mandi, IND.

Cureus
|November 24, 2025
PubMed

Insights

Primary percutaneous coronary intervention (PCI) improves outcomes for ST-elevation myocardial infarction (STEMI). Addressing physician misconceptions about PCI and pharmacoinvasive (PI) strategies is crucial for timely treatment in India.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Public Health

Background:

  • Primary percutaneous coronary intervention (PCI) is the standard treatment for ST-elevation myocardial infarction (STEMI).
  • Timely access to PCI in India is hindered by physician misconceptions regarding risks, efficacy compared to thrombolysis, referral timing, and pharmacoinvasive (PI) strategies.
  • Despite proven benefits, primary PCI utilization and timely STEMI reperfusion remain suboptimal in India.

Purpose of the Study:

  • To highlight the critical role of primary PCI in STEMI management.
  • To identify and address persistent myths and misconceptions among Indian primary care physicians that limit timely PCI referral.
  • To emphasize the importance of pharmacoinvasive (PI) strategies as an alternative in resource-limited settings.

Main Methods:

  • Review of existing evidence on primary PCI and pharmacoinvasive (PI) strategies in STEMI.
  • Analysis of barriers to timely PCI access in the Indian healthcare context.
  • Discussion of educational and systemic interventions to improve STEMI care.

Main Results:

  • Primary PCI is safe and highly effective, significantly reducing mortality, reinfarction, and stroke compared to thrombolysis.
  • Misconceptions regarding procedural risks, comparative effectiveness, and referral protocols impede optimal STEMI management.
  • Pharmacoinvasive (PI) therapy offers comparable outcomes to primary PCI in settings where timely PCI is not feasible.

Conclusions:

  • Overcoming physician misconceptions through targeted education and standardized protocols is essential for improving STEMI outcomes in India.
  • Strengthening STEMI networks and promoting evidence-based reperfusion strategies, including primary PCI and PI, are critical.
  • Optimizing reperfusion therapy requires addressing systemic delays and promoting the adoption of guideline-recommended treatments.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
203
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
222
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
744
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
278
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
206
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
329